Litcius/Paper detail

Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia)

Tetsuya Sakai, Shingo Matsumoto, Yasuto Ueda, Yuji Shibata, Takaya Ikeda, Atsushi Nakamura, Masahiro Kodani, Kadoaki Ohashi, Naoki Furuya, Hiroki Izumi, Kaname Nosaki, Shigeki Umemura, Yoshitaka Zenke, Hibiki Udagawa, Eri Sugiyama, Kiyotaka Yoh, Kōichi Goto

2023Journal of Thoracic Oncology23 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTrametinibDabrafenibLung cancerInternal medicineV600EOncologyProgression-free survivalCancer researchMutationCancerChemotherapyVemurafenibGeneMAPK/ERK pathwayKinaseGeneticsBiologyMetastatic melanomaLung Cancer Treatments and MutationsMelanoma and MAPK PathwaysFerroptosis and cancer prognosis
Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia) | Litcius